SAO PAULO - The leader of a truth commission investigating abuses during Brazil's 1964-85 military dictatorship lambasted German automaker Volkswagen AG at a hearing on Friday for providing what he called "unsatisfactory" testimony regarding its alleged ties with the regime.
BERLIN - Volkswagen stuck to its guidance for operating profit even after making record earnings last year, saying geopolitical risks and falling demand in key markets may weigh on business.
- A day after announcing it is to stop making GM-branded cars in Indonesia, General Motors said on Friday it would cease production of its Chevrolet Sonic in Thailand by the middle of this year.
BEIJING - General Motors will stop making GM-branded cars in Indonesia, a battleground for global automakers, closing an assembly plant, axing some 500 jobs and shifting its focus to sport utility vehicles (SUVs).
LONDON - Online car marketplace operator Auto Trader [TDMDG.UL] has announced its intention to proceed with a flotation on the London Stock Exchange, the company said on Thursday.
BEIJING - General Motors is to stop making cars in Indonesia, a battleground for global automakers in emerging Southeast Asia, closing an assembly plant, axing some 500 jobs and shifting its branding focus to sport utility vehicles (SUVs).
STOCKHOLM - Geely-owned carmaker Volvo Car Group said on Thursday its 2014 operating profit rose 17.5 percent in its best year of sales to date as rapid expansion in China and recovery in Europe took the sting off lingering weakness for the brand in the United States.
TOYOTA CITY/TOKYO - Toyota Motor Corp said on Wednesday it was "impossible" to meet union demands for a 13,300 yen ($112) monthly pay rise, as the automaker concluded the first day of labour talks widely considered crucial for Japan's economic recovery.
BERLIN/BOEBLINGEN - An inflation-busting wage deal for Germany's biggest labour union agreed on Tuesday looks set to boost household spending this year after consumer activity propelled strong growth in Europe's largest economy at the end of 2014.
- Bristol-Myers Squibb Co said it would buy privately held drugmaker Flexus Biosciences Inc for up to $1.25 billion (£811 million) to add an emerging class of cancer-fighting drugs to its pipeline.